Although several studies have shown a lower risk of non-Hodgkin lymphoma (NHL) in alcohol drinkers compared with nondrinkers, the dose-response relation and potential differences between former and current drinking and across beverage types and subtypes are unclear. The authors examined associations of alcohol intake with risk of NHL and NHL subtypes in the Cancer Prevention Study II Nutrition Cohort, a prospective study of US men and women aged 50-74 years. Between 1992 and 2007, there were 1,991 incident NHL cases among 143,124 participants. Multivariable-adjusted relative risks and 95% confidence intervals were computed using Cox proportional hazards regression. Compared with nondrinkers, the relative risk of NHL associated with former drinking was 0.90 (95% confidence interval (CI): 0.75, 1.10); the relative risks associated with current intakes of <1, 1-2, and >2 drinks/day were 0.93 (95% CI: 0.83, 1.03), 0.91 (95% CI: 0.78, 1.06), and 0.78 (95% CI: 0.65, 0.93), respectively. Associations did not differ by sex (P-interaction ¼ 0.45) or beverage type (P-difference ¼ 0.22). Alcohol intake was more strongly associated with B-cell lymphoma (P-trend ¼ 0.005) than with T-cell lymphoma (P-trend ¼ 0.76), and associations were similar among B-cell lymphoma subtypes. In this prospective study, current heavy alcohol intake was associated with a reduced risk of NHL. Associations did not differ by beverage type and were slightly stronger for B-cell tumors than for T-cell tumors. alcohol drinking; lymphoma, non-Hodgkin Abbreviations: CI, confidence interval; CPS-II, Cancer Prevention Study II; MET, metabolic equivalent; NHL, non-Hodgkin lymphoma.
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Early evidence of a possible inverse association between alcohol intake and risk of lymphoid neoplasms was reported in 2 studies where the observed number of lymphoma cases among alcoholics was lower than expected (1, 2) . Subsequently, the associations of alcoholic beverage intake with risk of lymphoma, non-Hodgkin lymphoma (NHL), and/or multiple myeloma were examined in at least 22 individual epidemiologic case-control studies , many of which showed lower risk in drinkers than in nondrinkers but little evidence of dose-response relations. Similarly, results of a large pooled analysis of 9 case-control studies with nearly 6,500 NHL cases and 8,700 controls showed a lower risk of NHL for current drinkers but not former drinkers, without evidence of a trend in risk with amount, frequency, or duration of intake (25) . Reasons for the consistent lack of dose-response relations between alcohol intake and risk of lymphoid neoplasms in case-control studies are unclear but might be related, at least in part, to methodological issues such as reliance on proxy respondents to report alcohol consumption in cases, inclusion of prevalent cases who might have changed their alcohol intake after diagnosis, differential participation rates between cases and controls based on alcohol intake, and/or changes in alcohol intake among cases due to early symptoms prior to diagnosis.
At least 8 prospective studies have examined the association of current alcohol consumption with risk of all lymphomas combined, NHL, and/or multiple myeloma (26) (27) (28) (29) (30) (31) (32) (33) . Only 4 of these studies (26, 28, 29, 31) showed statistically significant inverse dose-response relations with NHL overall. In contrast, in the California Teachers Study, which considered B-cell lymphomas only, there was no association between current drinking and risk, but there was a higher risk of B-cell NHL in former drinkers than in consistent nondrinkers (33) . In the only other prospective study to examine the relation with former drinking, Klatsky et al. (30) found a nonsignificantly lower risk of NHL in former drinkers than in lifelong abstainers. Furthermore, some prospective studies have suggested that the association of alcohol intake with NHL risk might differ by beverage type, but no consistent patterns have emerged (26, 28-30, 32, 33) . Similarly, findings from prospective studies (26) (27) (28) (29) (30) (31) (32) (33) show no clear differences in associations of alcohol intake with specific histologic subtypes of NHL. Limited power in some studies might have precluded detailed analyses by beverage type and specific histologic subtypes, particularly for higher amounts of alcohol.
The American Cancer Society's Cancer Prevention Study II (CPS-II) Nutrition Cohort is a large, prospective study of over 180,000 US men and women who reported their alcohol intake, smoking history, and other information in 1992. Because of its large sample size, with nearly 2,000 cases of NHL occurring over 15 years of follow-up, the CPS-II Nutrition Cohort provides an opportunity for assessing the associations of alcohol intake with the incidence of NHL in both men and women, within strata of histologic subtypes, and according to alcoholic beverage type. In addition, because cigarette smoking is associated with alcohol drinking and might be linked to an increased risk of NHL (34), we also examined associations of alcohol intake with risk in never smokers and ever smokers separately.
MATERIALS AND METHODS

Study population
The CPS-II Nutrition Cohort is a prospective study of cancer incidence and mortality in 86,402 men and 97,786 women and has been described in detail elsewhere (35) . Briefly, the Nutrition Cohort is a subgroup of the approximately 1.2 million participants in CPS-II, a prospective study of cancer mortality established by the American Cancer Society in 1982 (36) . Nutrition Cohort participants resided in 21 states with population-based cancer registries, were aged 50-74 years, and completed a 10-page confidential, selfadministered mailed questionnaire at enrollment in 1992 or 1993. The Emory University Institutional Review Board has approved all aspects of the CPS-II Nutrition Cohort protocol.
Excluded from this analysis were Nutrition Cohort participants who were lost to follow-up (i.e., were alive at the first follow-up questionnaire in 1997 but did not return the 1997 questionnaire or any subsequent follow-up questionnaires) (n ¼ 6,276), reported a personal history of cancer other than nonmelanoma skin cancer in 1992 (n ¼ 22,860), reported a diagnosis of lymphoma on the first survey that could not be verified through medical or cancer registry records (n ¼ 49), or were missing information on alcohol intake in 1992 (n ¼ 11,879). Included in the analysis were 68,339 men and 74,785 women.
Measurement of alcohol intake and other risk factors
This analysis was based on body weight, medical, behavioral, and other lifestyle information, and diet and alcohol intake as ascertained by self-report on the 1992 mailed questionnaire (height and previous alcohol use were reported in 1982). Alcoholic beverage intake was assessed in 1992 using the 68-item modified Block food frequency questionnaire (37) . Participants recorded their usual intake over the previous year of beer, wine or wine coolers, and liquor separately, according to serving size (i.e., small, medium, or large), and according to one of 9 possible frequencies (never or less than once per month, 1-3 drinks/month, 1 drink/week, 2-4 drinks/week, 5-6 drinks/week, 1 drink/day, 2-3 drinks/day, 4-5 drinks/day, or 6 drinks/day). Participants who reported consuming alcohol ''never or less than once per month'' for all 3 beverage types were classified as nondrinkers.
To standardize the definition of a ''drink,'' we calculated the number of drinks per day for each beverage by converting the reported serving size to grams using the Block conversions based on age, sex, beverage, and serving size (originally obtained from national survey data) (38) , multiplying that number by frequency to obtain grams per day, and then computing the number of drinks using US Department of Agriculture National Nutrient Database gram weight definitions for each beverage (12 fluid ounces (355 mL) of beer ¼ 356 g, 4 fluid ounces (118 mL) of wine or wine cooler ¼ 118 g, and 1.5 fluid ounces (44 mL) of liquor ¼ 42 g) (39) . The average total number of alcoholic drinks consumed per day was calculated by summing the contribution from each type. In the United States, a standard alcoholic beverage is estimated to contain approximately 14 g (0.6 ounces or 18 mL) of pure ethanol (40) . In addition, in a validation study using 4 random 24-hour recalls administered over a 1-year period as the comparison measure, the energyadjusted, deattenuated correlation coefficient for grams of alcoholic beverages reported was 0.80 for men and 0.79 for women (41) . The 1982 CPS-II baseline questionnaire also queried participants for information on alcohol intake. Participants who reported no alcohol consumption in 1982 or whose response was ''never or less than once per month'' for all beverage types in 1992 were considered consistent nondrinkers (heretofore referred to as nondrinkers), whereas participants who reported current or previous beverage consumption in 1982 but no alcoholic beverage consumption in 1992 were classified as former drinkers.
Ascertainment of NHL cases
Beginning in 1997, follow-up questionnaires were sent to cohort members every 2 years to update some exposure information and to ascertain self-reported, newly diagnosed cancers. All follow-up questionnaire response rates (after multiple mailings) among living cohort members were at least 89%. This analysis includes 1,991 (1,132 men and 859 women) verified incident cases of NHL diagnosed between the date of enrollment and June 30, 2007 . Of the cases initially identified by self-report of NHL on a follow-up questionnaire, 1,196 were subsequently verified from medical records and 412 were verified by linkage with state cancer registries. An additional 45 cases were initially self-reported as another type of cancer but were found to be NHL. Lastly, 338 incident cases were identified as interval deaths (deaths that occurred between baseline in 1992 and the end of follow-up in 2007) through automated linkage of the entire cohort with the National Death Index, and these cases were verified through linkage with state cancer registries.
The InterLymph Pathology Working Group classification, as described by Morton et al. (42) , was used to categorize NHL histologic subtypes based on the International Classification of Diseases for Oncology, Second and Third editions. The subtypes included in this analysis were all B-cell lymphoid neoplasms and T-cell lymphoid neoplasms. B-cell lymphoid neoplasms were further classified into chronic lymphocytic leukemia/small lymphocytic lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and other B-cell lymphoid neoplasms.
Statistical analyses
Participants were classified into 5 categories of alcohol intake: nondrinker, former drinker, and current intake of <1, 1-2, or >2 drinks/day. Body mass index was computed as weight in kilograms divided by height in meters squared, and was classified as <18.5, 18.5-<25, 25-<30, or 30. Cutpoints for quintiles of height were based on sex-specific distributions. Self-reported recreational physical activity at baseline was used to compute metabolic equivalent (MET)-hours/week as described previously for this cohort (43) . MET-hours/week were categorized as none, >0-<7, 7-<17.5, 17.5-<24.5, or 24.5. For reference, 24.5 MET-hours/week corresponds to approximately 1 hour of moderate-paced walking (3.0 miles/hour or 4.8 km/hour) 7 days a week. Participants who were missing data on body mass index, height, or MET-hours/week were assigned the median value for that variable. The relations of these variables and other potentially confounding factors with alcohol consumption were examined according to categories of alcoholic beverage intake, by sex. Person-years of follow-up for each participant were computed as the amount of time from completion of the Nutrition Cohort questionnaire in 1992/1993 to the date of 1) diagnosis of NHL, 2) death, 3) return of the last questionnaire (i.e., in 1997, 1999, 2001, 2003, 2005, or 2007 ), or 4) the last questionnaire on which the participant was known to be cancerfree if he/she reported a hematopoietic cancer that could not be verified. Cox proportional hazards regression (44) was used to compute adjusted relative risks and 95% confidence intervals for the association between alcohol intake and NHL incidence overall and for B-cell lymphomas, B-cell subtypes, and T-cell lymphomas. In all analyses, the reference group consisted of nondrinkers. All models included adjustment for age using the stratified Cox procedure, and in the analyses of men and women combined, results were adjusted for sex. Multivariable-adjusted models also included continuous variables for body mass index, height, and METhours/week and dummy variables for education, smoking status (i.e., never, former, or current smoker), and family history of hematopoietic cancer. Trend tests were conducted by assigning to each individual the median value of drinks/day corresponding to the category of intake and modeling this as a continuous variable. Former drinkers were not included in the trend tests. The Cox proportional hazards assumption was assessed, and no violations were observed.
For NHL overall, effect modification by sex and by smoking status (never smoker vs. ever smoker (current and former smokers were combined, since results did not differ between them)) was assessed by computing P values for multiplicative interactions, using likelihood ratio tests comparing Cox multivariable models with and without cross-product terms for categories of alcohol intake and sex or smoking status. The relative risks of NHL associated with intake of beer only, wine only, liquor only, and more than 1 beverage type, as compared with the reference group of nondrinkers, were computed in a mutually adjusted, multivariable model, and a Wald chi-square test was used to test the null hypothesis that the associations were equal. All analyses were performed using SAS software (SAS, version 9.2; SAS Institute Inc., Cary, North Carolina), and all tests of significance were 2-sided, with the level of significance set at P < 0.05.
RESULTS
Over a 15-year period, the 143,124 men and women included in this analysis contributed 1,779,472 person-years of follow-up. At baseline, the mean age was 64 years for men and 62 years for women. Mean age and height did not vary meaningfully across strata of alcohol intake in either sex (Tables 1 and 2 ). Mean body mass index increased across higher levels of alcohol intake in women but not in men, whereas mean MET-hours/week decreased across higher levels of intake in men and women. In both men and women, there was a higher proportion of African Americans, participants with less than a high school education, and never smokers among nondrinkers as compared with participants who consumed 1-2 or >2 drinks/day. Family history of hematopoietic cancer was not associated with alcohol intake in this cohort.
Although there was some evidence of a lower risk of NHL in former drinkers compared with nondrinkers, the 95% confidence intervals included the null value of 1 (Table 3) . Similarly, current alcohol intake was inversely related to the incidence of NHL in both men and women but was statistically significant only for consumption of >2 drinks/day; the test for linear trend was statistically significant for women and for both sexes combined. However, there was no significant interaction between alcohol intake and sex (multivariate v 2 ¼ 3.66 (4 df); P-interaction ¼ 0.45). After excluding the first 2 years of follow-up, results were largely the same; for men and women combined, the multivariable-adjusted relative risks of NHL associated with former drinking versus nondrinking and with current consumption of <1, 1-2, and >2 drinks/day versus nondrinking were 0.90 (95% confidence interval (CI): 0.74, 1.11), 0.94 (95% CI: 0.84, 1.05), 0.91 (95% CI: 0.77, 1.07), and 0.82 (95% CI: 0.68, 0.99), respectively (P-trend ¼ 0.05). In a sensitivity analysis in which multiple myeloma cases (or other plasma cell neoplasms) were excluded, the multivariable-adjusted relative risks of NHL associated with any former drinking and with current alcohol intake of <1, 1-2, and >2 drinks/day c Trend tests excluded former drinkers and were conducted by assigning to each individual the median value of drinks/day corresponding to the category of intake and modeling this as a continuous variable. The P-trend value (2-sided) was based on the Wald chi-square test.
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b Trend tests excluded former drinkers and were conducted by assigning to each individual the median value of drinks/day corresponding to the category of intake and modeling this as a continuous variable. The P-trend value (2-sided) was based on the Wald chi-square test. Results of analyses examining associations of alcohol intake with risk of NHL subtypes were similar in men and women (data not shown). Herein we present only the results for both sexes combined, because in the sex-specific analyses some of the cells had few cases. There was a statistically significant inverse association between alcohol intake and all B-cell lymphomas combined (Table 4) . Similar inverse relations were observed for each subtype of B-cell lymphoma, including multiple myeloma, but this was statistically significant only for chronic lymphocytic leukemia/small lymphocytic lymphoma (P-trend ¼ 0.04). For T-cell lymphomas, the multivariable-adjusted point estimates associated with <1, 1-2, and >2 drinks/day were all less than 1, but the 95% confidence intervals did not exclude the null value.
No evidence of interaction between alcohol intake and smoking status was observed (v 2 ¼ 1.73 (4 df); Pinteraction ¼ 0.79). For never smokers, the multivariableadjusted relative risk of NHL associated with consumption of >2 drinks/day was 0.65 (95% CI: 0.43, 0.99), whereas for ever smokers the comparable relative risk was 0.79 (95% CI: 0.64, 0.97). In addition, there was no evidence that the association between alcohol intake and NHL incidence differed by beverage type (P-difference ¼ 0.22) ( Table 5) .
DISCUSSION
In this large prospective study, current alcohol intake of >2 drinks/day was associated with a 22% lower risk of NHL in comparison with nondrinking among men and women. The inverse associations were stronger for B-cell lymphomas than for T-cell lymphomas and were similar among B-cell lymphoma subtypes. The relations of alcohol intake with risk of NHL were similar in never and ever smokers and for different types of alcoholic beverages.
The relation between alcohol intake and NHL risk observed in our study is similar to that of most, but not all, previously published prospective studies. In the Million Women Study (29) , which included 2,320 NHL cases (excluding multiple myeloma), the relative risks of NHL associated with intake of 7-14 and 15 drinks/week were 0.86 (95% CI: 0.78, 0.96) and 0.77 (95% CI: 0.62, 0.94), respectively. Results of at least 3 other prospective studies (26, (28) (29) 31 ) also showed statistically significant inverse associations, and to our knowledge no prospective study has shown a positive association between current alcohol intake and risk of NHL overall.
It is conceivable that the most common symptoms of lymphoma, such as enlarged lymph nodes, unexplained fever and weight loss, night sweats, and extreme fatigue, as well as the chronic diseases associated with lymphoma, might lead to a reduction in alcohol consumption prior to diagnosis, which would result in an apparent reduction in risk of disease. As we mentioned above, a recent analysis of data from the California Teachers Study found no association with current drinking but a higher risk of NHL in former drinkers compared with consistent nondrinkers (33) . Conversely, neither our study nor another large prospective study (30) found increased risks of NHL associated with former drinking.
While there is growing evidence that alcohol consumption is associated with a decreased risk of NHL overall, it is unclear whether risk differs for specific histologic subtypes. Indeed, NHL is a heterogeneous classification that encompasses the major histologic subtypes of T-cell and B-cell lymphoma, and further subclassification of the latter includes chronic lymphocytic leukemia/small lymphocytic lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple (32) did report a statistically significantly lower risk of diffuse large B-cell lymphoma associated with higher alcohol intake. Other prospective studies, including our own, have not observed consistent differences in associations across histologic subtypes (26) (27) (28) (29) (30) (31) (32) (33) . A pooled analysis might help to clarify this issue, since individual studies have limited power to detect meaningful associations for some subtypes and/or differences across subtypes.
In CPS-II, the reduced risk of NHL was observed for wine, liquor, and to a lesser extent beer intake. The large pooled analysis of case-control studies (25) and 2 other prospective studies (26, 29) also found similarly reduced risks of NHL associated with all beverage types. Importantly, the large size of this study allowed for a stratified analysis of beverage type in which participants who consumed more than one type were considered separately, whereas in other studies the analyses adjusted for type of beverage consumed, which could have resulted in residual confounding.
The biologic mechanism underlying an association between alcohol intake and a reduced risk of NHL is not fully understood. In a review of the literature on the effects of alcohol consumption on immunologic status, Díaz et al. (45) noted that low-to-moderate alcohol consumption (defined as up to 2 drinks/day for men and 1 drink/day for women) might enhance immunocompetence, potentially reducing risk of lymphoid cancers. Conversely, heavy (particularly excessive) consumption may have the opposite effect. In our study, the highest category of alcohol intake was >2 drinks/day, and consumption at this level was associated with a reduced risk of NHL. Unfortunately, there were too few cases to examine the association between alcohol intake and risk of lymphoma at higher amounts; therefore, a potential U-shaped relation cannot be ruled out. Moreover, using a human lymphoma xenograft mouse model, Hagner et al. (46) showed that chronic exposure to 5% or 10% alcohol in water (an amount shown to lead to 0.05-0.15 g/dL alcohol in circulation) decreases lymphoma growth, at least partly because of inhibition of mTOR signaling.
The major strengths of this study include the availability of detailed exposure data collected prior to diagnosis of NHL from a very large, nationwide cohort of men and women. In addition, the size of the cohort allowed for assessment of associations stratified by sex, smoking status, NHL histologic subtype, and specific alcoholic beverage type. Despite these strengths, the principal limitations of the study should be recognized. Participants might have underreported their alcohol intake, which would have attenuated the associations, since any misclassification is likely to have been nondifferential between those who developed NHL and those who did not. However, previous reports from this cohort have shown well-established associations between alcohol intake and higher breast cancer incidence (47) and lower overall and cardiovascular disease mortality (48) . Second, we did not have information on the known infectious causes of NHL. However, because infectious agents are associated with only a few rare forms of NHL, they are unlikely to confound an inverse association of alcohol intake with NHL risk.
In summary, findings from the prospective study presented here support the hypothesis that alcohol intake might be associated with a reduced risk of NHL. Furthermore, they indicate no statistically significant association with former intake and no difference in associations between men and women, between ever and never smokers, among NHL subtypes, or by beverage type. Although these findings are consistent with those of most other cohort studies, the recommendation to limit alcohol intake to no more than 1 drink/day for women and 2 drinks/day for men (49) remains warranted, given the established adverse relations of alcohol consumption with many other cancers (including commonly occurring cancers, such as breast and colorectal cancer), other health conditions, and accidents.
